High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis.

Omri A ArbivJeongMin M KimMarie YanKamila RomanowskiJonathon R CampbellAnete TrajmanLeyla AsadiFederica FregoneseNicholas WintersDick MenziesJames C Johnston

Published in: Thorax (2022)

HDRs were not associated with a significant difference in SAEs, 2-month culture conversion or death. Further studies are required to identify specific groups who may benefit from HDR.

Keyphrases

high dose
low dose
mycobacterium tuberculosis
stem cell transplantation
combination therapy